California votes to boost stem cell research funding

Carly Behm -   Print  |
Listen

Voters approved a proposition to provide $5.5 billion for stem cell research by the California Institute of Regenerative Medicine, according to a Nov. 13 press release.

Proposition 14, the California Stem Cell Research, Treatments and Cures Initiative of 2020, will provide a boost to the institute through a general obligation bond fund, according to the release.

Californians for Cures, the organization behind the campaign to approve the proposition, said the funding will drive research and development of treatments for illnesses and conditions including neurodegenerative diseases, strokes and more, according to a Nov. 12 press release.

"We are already working on ways to repay that trust and bring stem cell and regenerative therapies to all the people of this great state, particularly for communities that have traditionally been overlooked or underserved," Jonathan Thomas, PhD, CIRM board chair, said in the statement.

Read the CIRM press release here and information from Californians for Cures here.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers